Monitoring treatment and managing adherence in schizophrenia.

Abstract

The majority of patients with schizophrenia will be nonadherent at some point during their treatment, which is why clinicians must assess adherence at each visit and promptly address any barriers. Treatment adherence can be negatively impacted by substance use, cognitive impairment, complex treatment regimens, and antipsychotic-induced adverse effects… (More)
DOI: 10.4088/JCP.12117tx2c

Topics

Cite this paper

@article{Marder2013MonitoringTA, title={Monitoring treatment and managing adherence in schizophrenia.}, author={Stephen R. Marder}, journal={The Journal of clinical psychiatry}, year={2013}, volume={74 10}, pages={e21} }